[Primary osteoporosis--its diagnosis and treatment].
Inaba
Masaaki
M
Department of Metabolism, Endocrinology, and Molecular Medicine, Osaka City University Graduate School of Medicine.
D015502:Absorptiometry, Photon; D000469:Alkaline Phosphatase / Q000032:analysis; D015415:Biomarkers / Q000032:analysis; D015519:Bone Density; D050071:Bone Density Conservation Agents / Q000627:therapeutic use; D004164:Diphosphonates / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D050723:Fractures, Bone / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D010024:Osteoporosis / Q000145:classification / Q000175:diagnosis* / Q000188:drug therapy* / Q000209:etiology; D010446:Peptide Fragments / Q000032:analysis; D011347:Procollagen / Q000032:analysis; D020845:Selective Estrogen Receptor Modulators / Q000627:therapeutic use; D014807:Vitamin D / Q000627:therapeutic use
D015415:Biomarkers; D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D010446:Peptide Fragments; D011347:Procollagen; D020845:Selective Estrogen Receptor Modulators; C047202:procollagen Type I N-terminal peptide; D014807:Vitamin D; D000469:Alkaline Phosphatase